Evidence map›Paper›PMID 20844042›Full record

ArticleJournal of virology2010

The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.

Chunling Hu, Dyana T Saenz, Hind J Fadel, William Walker, Mary Peretz, Eric M Poeschla

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Mechanism of HIV-1 Capsid Rupture and Uncoating by Reverse Transcription.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Genome research · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Targeting the HIV RNA genome: high-hanging fruit only needs a longer ladder.Current topics in microbiology and immunology · 2015
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. HIV Restriction Factors and Mechanisms of Evasion.Cold Spring Harbor perspectives in medicine · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chunling HuDepartment of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Dyana T Saenz
Hind J Fadel
William Walker
Mary Peretz
Eric M Poeschla
Mayo Clinic · US

Funding

LEDGF/p7 and HIV IntegrationR01AI077344 · NIAID · UNIVERSITY OF COLORADO DENVER · PI POESCHLA, ERIC M. · 2008 to 2018
$4.1M
NOVEL LENTIVIRAL VECTORS FOR SUSTAINED GENE EXPRESSIONR01AI047536 · NIAID · MAYO CLINIC ROCHESTER · PI POESCHLA, ERIC M. · 1999 to 2008
$1.8M
Lentiviral Genome ProcessingR21AI047536 · NIAID · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI POESCHLA, ERIC M. · 2003 to 2003
$292k
NIAID NIH HHS AI47536NIAID NIH HHS AI77344NIAID NIH HHS R01 AI047536NIAID NIH HHS R01 AI077344NIAID NIH HHS R21 AI047536
6 · The paper itself

Abstract

HIV-1 and certain other retroviruses initiate plus-strand synthesis in the center of the genome as well as at the standard retroviral 3' polypurine tract. This peculiarity of reverse transcription results in a central DNA "flap" structure that has been of controversial functional significance. We mutated both HIV-1 flap-generating elements, the central polypurine tract (cPPT) and the central termination sequence (CTS). To avoid an ambiguity of previous studies, we did so without affecting integrase coding. DNA flap formation was disrupted but single-cycle infection was unaffected in all target cells tested, regardless of cell cycle status. Spreading HIV-1 infection was also normal in most T cell lines, and flap mutant viruses replicated equivalently to the wild type in nondividing cells, including macrophages. However, spreading infection of flap mutant HIV-1 was impaired in non-vif-permissive cells (HuT78, H9, and primary human peripheral blood mononuclear cells [PBMCs]), suggesting APOBEC3G (A3G) restriction. Single-cycle infections confirmed that vif-intact flap mutant HIV-1 is restricted by producer cell A3G/F. Combining the Δvif and cPPT-CTS mutations increased A3G restriction synergistically. Moreover, RNA interference knockdown of A3G in HuT78 cells released the block to flap mutant HIV-1 replication. Flap mutant HIV-1 also accrued markedly increased A3G-mediated G→A hypermutation compared to that of wild-type HIV-1 (a full log(10) in the 0.36 kb downstream of the mutant cPPT). We suggest that the triple-stranded DNA structure, the flap, is not the consequential outcome. The salient functional feature is central plus-strand initiation, which functions as a second line of defense against single-stranded DNA editing by A3 proteins that survive producer cell degradation by Vif.

Indexed as

Amino Acid SequenceAPOBEC-3G DeaminaseBase SequenceCell LineCytidine DeaminaseCytosine DeaminaseHIV-1HIV InfectionsHumansMolecular Sequence DataMutationPurinesReverse TranscriptionRNA, ViralVirus ReplicationAPOBEC3F protein, humanAPOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine DeaminaseCytosine DeaminasePurinesRNA, Viral

Identifiers

PMID20844042
PMCPMC2977901
OpenAlexW2112705626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.